CLINICAL_TRIALS trial_result · 2023-05-03

Clinical Trial Update: A Study of TAK-919 in Healthy Japanese Adults (COVID-19) [Phase 1, Phase 2]

Phase 1/2 clinical trial of TAK-919 in healthy Japanese adults for COVID-19 has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Takeda | Conditions: Coronavirus Disease (COVID-19) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-05-03